Vaccination against COVID-19 can reduce the severity and duration of COVID

Published Date: 02 Mar 2023

Vaccination against SARS-CoV-2, the virus that causes COVID-19, can reduce the severity and duration of COVID in people who have persistent symptoms after infection, he said.

Read Full News

Latest News

US FDA Says False-positive Lettuce Test Doesn't Change Taylor Farms Cyclospora Probe

The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be ⁠a false positive for cyclospora, saying the reversal does not...

What Has Made the Cyclospora Behind the US Outbreak So Challenging to Trace?

Cyclospora, the parasite behind thousands of suspected U.S. cases of a foodborne illness, has a long incubation period, and samples cannot be cultured in labs, making it...

Japanese Drugmaker Takeda's Qdenga Becomes First Dengue Vaccine Approved in India

Takeda Pharmaceutical's dengue vaccine Qdenga has been approved by India's drug regulator, making it the first such vaccine to be cleared in the country, the Japanese...

India's Serum Institute Partners With Gates MRI to Make Experimental TB Vaccine

(Corrects to fix typo in the headline)

New Zealand Confirms First H5N1 Bird Flu Case in Native Bird

New Zealand detected on Friday the first infection of a native bird ⁠by the deadly H5N1 bird flu, days after confirming a migratory seabird had tested ⁠positive in the...

Congo Begins Trial Of Gilead's Experimental Antiviral for Ebola Bundibugyo

Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in ⁠a trial testing Gilead Sciences' experimental antiviral...

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be ⁠a false positive for cyclospora, saying the reversal does not...

Cyclospora, the parasite behind thousands of suspected U.S. cases of a foodborne illness, has a long incubation period, and samples cannot be cultured in labs, making it...

Takeda Pharmaceutical's dengue vaccine Qdenga has been approved by India's drug regulator, making it the first such vaccine to be cleared in the country, the Japanese...

(Corrects to fix typo in the headline)

New Zealand detected on Friday the first infection of a native bird ⁠by the deadly H5N1 bird flu, days after confirming a migratory seabird had tested ⁠positive in the...

Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in ⁠a trial testing Gilead Sciences' experimental antiviral...

News All Time

Effort to End Respiratory Viruses to Start With Cold & Flu

The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.

US Provisional Mortality Rate Falls 4.6% in 2025, Flu Deaths Rise

The U.S. provisional death rate fell 4.6% in 2025, with heart disease, cancer and unintentional injuries remaining the leading causes of mortality, ⁠the Centers for Disease...

Bangladesh Warns Of Dengue Surge as Weather Aids Spread

Bangladesh could face a sharp increase in dengue infections over the next two months, health experts warned, as wet ⁠weather and inadequate mosquito control spur a wider...

Uganda Finds Isolated Marburg Virus Case, Africa CDC Says

Ugandan health authorities have confirmed an isolated case of Marburg virus disease, a highly infectious hemorrhagic ⁠fever, while conducting surveillance for an Ebola...

WHO Recommends Doxycycline PEP to Prevent Bacterial STIs

WHO’s first guidance on doxyPEP prioritizes high-risk groups while emphasizing antimicrobial resistance monitoring and responsible implementation.

Congo Bans Gatherings in Kinshasa and Three Provinces Over Ebola Outbreak

The Democratic Republic of Congo has banned public gatherings in four provinces, including the capital, Kinshasa, as ⁠the country battles a deadly Ebola...

Ebola Outbreak Could Cost Africa Up to $3.6 Billion, UN Says

(Edits headline to spell out 'billion')

Can Early Metformin Treatment Prevent Long COVID Symptoms?

Early metformin treatment in mild-to-moderate COVID may not prevent long-term symptoms but is linked to relatively fewer clinician-diagnosed cases, a study finds.

Africa CDC Seeks $18 Million in Urgent Support for Ebola Drug Trials in DRC

The Africa Centres for Disease Control and Prevention on Tuesday called for $18 million in urgent ⁠funding to support trials of experimental Ebola treatments in the...

WHO Issues Clinical Care Advice for Ebola

New recommendations focus on supportive care, shared decision-making, and infection control.

Congo Says Number Of Confirmed Ebola Cases At 1,274, Including 360 Deaths

⁠The Democratic ⁠Republic ⁠of Congo ‌said late on ‌Sunday that ‌confirmed ‌Ebola ⁠cases ‌in ⁠the country ‌had reached 1,274, including ‌360...

Antiretroviral Therapy

Review clinical reference information, guidelines, and medical news on antiretroviral therapy, HIV treatment, and AIDS treatment. Learn about antiretroviral treatment including antiretroviral medications and HIV drugs.

Congo Says Number Of Confirmed Ebola Cases Rises to 1,155

The number of confirmed ⁠Ebola cases in the Democratic Republic ⁠of Congo has increased to ⁠1,155, including ‌304 deaths, government data showed on Thursday.

EU Commission Opens Antitrust Probe Into Sanofi's Flu Vaccine Campaign

The European Commission opened an investigation on ⁠Friday into whether French drugmaker Sanofi breached EU competition ⁠rules in a flu vaccine marketing...

US Military Requires Flu Vaccine for Some After Outbreak in Texas Training Center

The U.S. military has resumed requiring flu vaccines for some service members in an exception to Defense ⁠Secretary Pete Hegseth's guidance declaring the shots voluntary two...

Africa CDC Says Funding Needs for Ebola Response Three Times Higher At $1.4 Billion

Africa's top public health agency said on Thursday that funding needed ⁠to tackle the continent's Ebola outbreak was three times higher than an earlier estimate, and now...

Recommended News For You

Charles III, King of Kings, is Cancerous.

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

Radiation therapy can promote amphiregulin, which increases growth of metastases

Recommended Articles For You

Seeing the Unseen: Examining Chancroid Through Images 

Multiple Myeloma: Understanding the Basics  

Unlocking the Potential of Palbociclib: A Comprehensive Overview 

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

2.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

3.

Prostate cancer Q&A: Improving detection and reducing overtreatment

4.

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

5.

How 7,000 steps a day could help reduce your risk of cancer

1.

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed

2.

Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights

3.

How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?

4.

Comprehensive Applications in Oncology and Quality Improvement

5.

Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

5.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot